Publications

• Achieving Depth of Response in Skin Clearance and Itch Relief With Lebrikizumab is Associated With Minimal Impact of Atopic Dermatitis on Quality of Life

  SKIN: Journal of Cutaneous Medicine Jan 2025
  1. Raj Chovatiya
  2. Eric Simpson
  3. Tilo Biedermann
  4. Leon Kircik
  5. Vivian Y. Shi
  6. Ignasi Figueras-Nart
  7. Marta Casillas
  8. Gaia Gallo
  9. Yuxin Ding
  10. Hong Zhang
  11. Evangeline Pierce
  12. Helena Agell
  13. Christian Vestergaard

• CERS1 is a biomarker of Staphylococcus aureus abundance and atopic dermatitis severity

  Journal of Allergy and Clinical Immunology 2024
  1. H. Mark Kenney
  2. Takeshi Yoshida
  3. Evgeny Berdyshev
  4. Agustin Calatroni
  5. Steven R. Gill
  6. Eric L. Simpson
  7. Stephanie Lussier
  8. Mark Boguniewicz
  9. Tissa Hata
  10. Zelma C. Chiesa Fuxench
  11. Anna De Benedetto
  12. Peck Y. Ong
  13. Justin Ko
  14. Wendy Davidson
  15. Gloria David
  16. Patrick M. Schlievert
  17. Donald Y.M. Leung
  18. Lisa A. Beck

• Lebrikizumab Confirms a Consistent Safety Profile in Adults and Adolescents With Moderate-to-Severe Atopic Dermatitis

  SKIN: Journal of Cutaneous Medicine Jan 2025
  1. Linda Stein Gold
  2. Eric Simpson
  3. Diamant Thaçi
  4. Alan Irvine
  5. Marjolein de Bruin-Weller
  6. Gaia Gallo
  7. Maria Lucia Buziqui Piruzeli
  8. Hany Elmaraghy
  9. Jinglin Zhong
  10. Sonia Montmayeur
  11. Ruth Coll
  12. Mark G. Lebwohl

• Long-Term Safety and Efficacy with Roflumilast Cream 0.15% in Patients Aged ≥6 Years with Atopic Dermatitis

  Dermatitis 2025
  1. Eric L. Simpson
  2. Lawrence F. Eichenfield
  3. Kim A. Papp
  4. Seth B. Forman
  5. Adelaide A. Hebert
  6. Mercedes E. Gonzalez
  7. Melinda J. Gooderham
  8. H. Chih Ho Hong
  9. Vimal H. Prajapati
  10. Emma Guttman-Yassky
  11. Jonathan I. Silverberg
  12. Melissa S. Seal
  13. David Krupa
  14. Erin Almaraz
  15. Diane Hanna
  16. Patrick Burnett
  17. Scott Snyder
  18. David H. Chu
  19. Robert C. Higham
  20. David R. Berk

• Tapinarof Improved Outcomes and Sleep for Patients and Families in Two Phase 3 Atopic Dermatitis Trials in Adults and Children

  Dermatology and Therapy Jan 2025
  1. Eric L. Simpson
  2. Adelaide A. Hebert
  3. John Browning
  4. Rocco T. Serrao
  5. Howard Sofen
  6. Philip M. Brown
  7. Stephen C. Piscitelli
  8. David S. Rubenstein
  9. Anna M. Tallman

• The effect of dupilumab on caregiver- and patient-reported outcomes in young children with moderate-to-severe atopic dermatitis

  Journal of the American Academy of Dermatology Jan 2025
  1. Amy S. Paller
  2. Jonathan I. Silverberg
  3. Eric L. Simpson
  4. Michael J. Cork
  5. Peter D. Arkwright
  6. Zhen Chen
  7. Ashish Bansal
  8. Randy Prescilla
  9. Zhixiao Wang
  10. Ainara R. Marco

• The efficacy of longer-term lebrikizumab treatment in patients with moderate-to-severe atopic dermatitis who did not meet protocol-defined response criteria at week 16 in 2 randomized controlled clinical trials

  Journal of the American Academy of Dermatology 2025
  1. Emma Guttman-Yassky
  2. David Rosmarin
  3. Marjolein de Bruin-Weller
  4. Stephan Weidinger
  5. Thomas Bieber
  6. H. Chih ho Hong
  7. Hany Elmaraghy
  8. Amber Reck Atwater
  9. Evangeline Pierce
  10. Chenjia Xu
  11. Helena Agell
  12. Esther Garcia Gil
  13. Eric Simpson

• Achievement of No-to-minimal Itch and Sleep Improvement with Tapinarof Cream 1% Once Daily in Two Pivotal Phase 3 Trials in Adults and Children Down to 2 Years of Age with Atopic Dermatitis

  SKIN: Journal of Cutaneous Medicine Nov 2024
  1. Eric Simpson
  2. Dareen D. Siri
  3. Raj Chovatiya
  4. Mona Shahriari
  5. Autumn F. Burnette
  6. Brittany G. Craiglow
  7. Philip M. Brown
  8. Anna M. Tallman

• A practical guide to using oral Janus kinase inhibitors for atopic dermatitis from the International Eczema Council

  The British journal of dermatology Dec 23, 2024
  1. Carter Haag
  2. Andrew Alexis
  3. Valeria Aoki
  4. Robert Bissonnette
  5. Andrew Blauvelt
  6. Raj Chovatiya
  7. Michael J. Cork
  8. Simon G. Danby
  9. Lawrence F. Eichenfield
  10. Kilian Eyerich
  11. Melinda Gooderham
  12. Emma Guttman-Yassky
  13. Dirk Jan Hijnen
  14. Alan D. Irvine
  15. Norito Katoh
  16. Dedee F. Murrell
  17. Yael A. Leshem
  18. Adriane A. Levin
  19. Ida Vittrup
  20. Jill I. Olydam
  21. Raquel L. Orfali
  22. Amy S. Paller
  23. Yael Renert-Yuval
  24. David Rosmarin
  25. Jonathan I. Silverberg
  26. Jacob P. Thyssen
  27. Sonja Ständer
  28. Nicholas Stefanovic
  29. Gail Todd
  30. Jia De Yu
  31. Eric L. Simpson

• A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 16-Week Trial to Evaluate the Efficacy and Safety of FB-401 in Children, Adolescents, and Adult Subjects (Ages 2 Years and Older) with Mild-to-Moderate Atopic Dermatitis

  Dermatology Feb 1, 2024
  1. Michael E. Jacobson
  2. Ian A. Myles
  3. Amy S. Paller
  4. Lawrence F. Eichenfield
  5. Eric L. Simpson

• Burden of atopic dermatitis in paediatric patients

  British Journal of Dermatology Jun 2024
  1. Stephan Weidinger
  2. Eric L. Simpson
  3. Jonathan I. Silverberg
  4. Sebastien Barbarot
  5. Laurent Eckert
  6. Paola Mina-Osorio
  7. Ana B. Rossi
  8. Lysel Brignoli
  9. Tarek Mnif
  10. Isabelle Guillemin
  11. Miriam C. Fenton
  12. Dimittri Delevry
  13. Chien Chia Chuang
  14. Marine Pellan
  15. Abhijit Gadkari

• Characterization of disease burden, treatment and comorbidities in a large, real-world cohort of patients with atopic dermatitis

  JAAD International Jun 2024
  1. Jonathan I. Silverberg
  2. Angel Cronin
  3. Eric A. Jones
  4. Swapna S. Dave
  5. Robert R. McLean
  6. Jeffrey Greenberg
  7. Bruce Strober
  8. Thomas Bieber
  9. Melinda Gooderham
  10. Amy S. Paller
  11. Eric L. Simpson

• Disease burden and patient characteristics associated with systemic therapy utilization among adults with atopic dermatitis

  Journal of Dermatological Treatment 2024
  1. Jonathan I. Silverberg
  2. Linda Stein Gold
  3. Seemal Desai
  4. Alexandra Golant
  5. Douglas DiRuggiero
  6. D. Christian Fenske
  7. Alvin Li
  8. Zach Dawson
  9. Yolanda Muñoz Maldonado
  10. Kaylee Ho
  11. Kayla Callahan
  12. Eric L Simpson

• Dupilumab Safety and Efficacy up to 1 Year in Children Aged 6 Months to 5 Years with Atopic Dermatitis

  American Journal of Clinical Dermatology Jul 2024
  1. Amy S. Paller
  2. Elaine C. Siegfried
  3. Eric L. Simpson
  4. Michael J. Cork
  5. Robert Sidbury
  6. Iris H. Chen
  7. Faisal A. Khokhar
  8. Jing Xiao
  9. Ariane Dubost-Brama
  10. Ashish Bansal

• Dupilumab treatment improves signs, symptoms, quality of life, and work productivity in patients with atopic hand and foot dermatitis

  Journal of the American Academy of Dermatology 2024
  1. Eric L. Simpson
  2. Jonathan I. Silverberg
  3. Margitta Worm
  4. Golara Honari
  5. Koji Masuda
  6. Ewa Syguła
  7. Marie L.A. Schuttelaar
  8. Eric Mortensen
  9. Elizabeth Laws
  10. Bolanle Akinlade
  11. Naimish Patel
  12. Jennifer Maloney
  13. Heather Paleczny
  14. Dimittri Delevry
  15. Jing Xiao
  16. Ariane Dubost-Brama
  17. Ashish Bansal

• Durable improvements in atopic dermatitis in the head and neck and across other anatomic regions with rocatinlimab

  Archives of Dermatological Research Dec 2024
  1. Emma Guttman-Yassky
  2. Ehsanollah Esfandiari
  3. Hirotaka Mano
  4. Takahiro Arai
  5. Alan D. Irvine
  6. Michael J. Cork
  7. Kenji Kabashima
  8. Camilla Chong
  9. Eric Simpson

• Efficacy and safety of rademikibart (CBP-201), a next-generation mAb targeting IL-4Rα, in adults with moderate to severe atopic dermatitis

  Journal of Allergy and Clinical Immunology Apr 2024
  1. Jonathan I. Silverberg
  2. Bruce Strober
  3. Brian Feinstein
  4. Jinhua Xu
  5. Emma Guttman-Yassky
  6. Eric L. Simpson
  7. Pauline Li
  8. Malinda Longphre
  9. Jing Song
  10. Jiawang Guo
  11. Jang Yun
  12. Belinda Williams
  13. Wubin Pan
  14. Selwyn Ho
  15. Raúl Collazo
  16. Zheng Wei

• Efficacy, Safety, and Long-Term Disease Control of Ruxolitinib Cream Among Adolescents with Atopic Dermatitis

  American Journal of Clinical Dermatology Jul 2024
  1. Lawrence F. Eichenfield
  2. Eric L. Simpson
  3. Kim Papp
  4. Jacek C. Szepietowski
  5. Andrew Blauvelt
  6. Leon Kircik
  7. Jonathan I. Silverberg
  8. Elaine C. Siegfried
  9. Michael E. Kuligowski
  10. May E. Venturanza
  11. Howard Kallender
  12. Haobo Ren
  13. Amy S. Paller

• Emollient application from birth to prevent eczema in high-risk children

  Health Technology Assessment Jul 2024
  1. Lucy E. Bradshaw
  2. Laura A. Wyatt
  3. Sara J. Brown
  4. Rachel H. Haines
  5. Alan A. Montgomery
  6. Michael R. Perkin
  7. Tracey H. Sach
  8. Sandra Lawton
  9. Carsten Flohr
  10. Matthew J. Ridd
  11. Joanne R. Chalmers
  12. Joanne Brooks
  13. Richard Swinden
  14. Eleanor J. Mitchell
  15. Stella Tarr
  16. Nicola Jay
  17. Kim S. Thomas
  18. Hilary Allen
  19. Michael J. Cork
  20. Maeve M. Kelleher
  21. Eric L. Simpson
  22. Stella T. Lartey
  23. Susan Davies-Jones
  24. Robert J. Boyle
  25. Hywel C. Williams

• Evaluating the clinical utility of the Atopic Dermatitis Control Tool

  British Journal of Dermatology Jun 2024
  1. Eric L. Simpson
  2. Laurent Eckert
  3. Abhijit Gadkari
  4. T. Michelle Brown
  5. Peter A. Lio
  6. Benjamin Lockshin
  7. Lauren Nelson
  8. Sheri E. Fehnel
  9. Puneet Mahajan
  10. Jingdong Chao
  11. Michaela Nygårdas
  12. Isabelle Guillemin

• How to use the Harmonising Outcome Measures for Eczema Core Outcome Set for atopic dermatitis trials

  British Journal of Dermatology Apr 2024
  1. Kim S. Thomas
  2. Laura Howells
  3. Yael A. Leshem
  4. Eric L. Simpson
  5. Christian Apfelbacher
  6. Phyllis I. Spuls
  7. Louise A.A. Gerbens
  8. Michael E. Jacobson
  9. Norito Katoh
  10. Hywel C. Williams
  11. Beth L. Stuart

• Impact of atopic dermatitis lesion locations and extent on patient burden

  JEADV Clinical Practice 2024
  1. Eric Simpson
  2. Peter Lio
  3. Evangeline Pierce
  4. Angel Cronin
  5. Robert R. McLean
  6. Thomas Eckmann
  7. Amber Reck Atwater
  8. Zach Dawson
  9. Jonathan I. Silverberg

• Improvement Across Dimensions of Disease with Lebrikizumab Use in Atopic Dermatitis

  Advances in Therapy 2024
  1. Eric Simpson
  2. Pablo Fernández-Peñas
  3. Marjolein de Bruin-Weller
  4. Peter A. Lio
  5. Chia Yu Chu
  6. Khaled Ezzedine
  7. Helena Agell
  8. Marta Casillas
  9. Yuxin Ding
  10. Fan Emily Yang
  11. Evangeline Pierce
  12. Thomas Bieber